一个癌细胞选择性复制压力纳米放大器促进复制叉灾难克服放射电阻
Hongwei Liao1, Shengfei Yang1, Zeyu Liang1,2
1Institute of Pharmaceutics, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
ACS nano
|September 14, 2023
概括
这项研究引入了一种新型纳米放大器,可以选择性地放大癌细胞中的复制应激,从而提高放射治疗的疗效. 这种方法克服了癌细胞的放射电阻,而不会伤害正常细胞.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 复制应激 (RS) 对放射治疗的抗癌作用至关重要,但也与癌细胞的放射电阻有关.
- 放大RS是一种增强放射治疗的有希望的策略,但选择性RS放大器尚未得到开发.
研究的目的:
- 开发和评估一种新的纳米放大器,用于选择性复制癌细胞的应力放大.
- 为了研究这个纳米放大器在克服癌细胞电阻和提高放射治疗疗效方面的潜力.
主要方法:
- 开发一个复制应力纳米放大器 (RSNA) 使用催化FePt纳米颗粒装载多克索鲁比 (DOX).
- 研究RSNA的机制:将活性氧物种 (ROS) 转化为氧,促进复制叉 (RF) 灾难,以及S相积累.
- 评估RSNA对放射治疗疗效和癌细胞选择性的影响.
主要成果:
- 通过促进复制叉灾难,RSNA选择性地加剧癌细胞中的复制压力.
- 通过增加模板病变和RF崩成双链断裂,RSNA增强了放射治疗对DNA的破坏性作用.
- RSNA预治疗使癌细胞对放射治疗敏感,并克服放射电阻,而不影响正常细胞.
结论:
- 使用RSNA选择性放大复制应激是一种可行的策略,可以提高放射治疗的疗效.
- 通过最大限度地增加复制应激,RSNA提供了一种有希望的方法来克服癌细胞的放射电阻.
- 开发的RSNA通过改善放射治疗结果,证明了针对性癌症治疗的潜力.
相关概念视频
01:02The DNA Replication Fork
36.1K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
36.1K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
02:37Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:37DNA Damage Can Stall the Cell Cycle
2.6K
2.6K